ELOCTATE® Patient Support
HemAssist provides the access, education, and ongoing support you need from Sanofi for your hemophilia A journey with ELOCTATE.
Take the first step with HemAssist
Once you’ve been prescribed ELOCTATE, you can enroll in HemAssist to get the support you need to start and stay with treatment. We offer financial assistance for eligible patients, help you navigate insurance, and provide supplemental infusion training.
After you enroll, your HemAssist team will call you within 24 hours to welcome you to the program and explain what to expect. Save 1-833-723-5463 to your contacts. Learn how to enroll
OUR SUPPORT
Affording ELOCTATE
No matter your situation, we are committed to helping you access and afford treatment. Your team will verify your insurance coverage and determine what financial assistance programs you may be eligible for.
Starting treatment
Your team can help you get started with ELOCTATE right away. We offer supplemental infusion training, make sure you receive medication, and offer tips to help you build a treatment routine.
Ongoing support
Our team provides support and guidance throughout your ELOCTATE journey. This includes helping you maintain motivation to stay with your treatment as prescribed, navigate new insurance, and more.
Financial assistance
Whether you have commercial insurance, government insurance, or are experiencing a gap in insurance, our team is here to help. If you need help paying for medication, we can help determine if you may be eligible for financial assistance.
Copay Assistance Program*
If you have commercial insurance (insurance sponsored by your employer or private insurance) and you’re having trouble paying for ELOCTATE, HemAssist's Copay Assistance Program may be able to help. Get ELOCTATE for as little as $0.
Free Trial Program†
Patients prescribed ELOCTATE for the first time can receive their first 30-day supply of treatment generally within 24 to 48 hours with a valid prescription from their healthcare provider through the Free Trial Program†. While you and your healthcare provider are deciding what treatment is right for you, a dedicated HemAssist Case Manager will review your health insurance information and coverage for your prescribed medication. Once the enrollment is complete, your Case Manager will contact you within 24 hours with next steps.
Patient Assistance Program†
HemAssist’s Patient Assistance Program may be available to help eligible ELOCTATE patients who are uninsured, underinsured, or experiencing a temporary loss in insurance coverage.
*Not valid if the patient is utilizing a state or federally funded health insurance program such as Medicare (including Medicare Part D), Medicaid, Medigap, VA, DoD, TRICARE®, state pharmaceutical assistance program, etc. to pay in part or in full for their ELOCTATE prescription. Not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Copay Program at any time without notice. Savings by patients may vary depending on their out-of-pocket costs. The program is intended to help patients afford their ELOCTATE prescription. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms.
† Free Trial valid only for a patient’s first prescriptions and it is limited to one use per patient per product for their lifetime. Free Trial not valid in Vermont. Claims for free products dispensed through the Free Trial or Patient Assistance Programs shall not be submitted to any third-party payer, public or private (e.g. private insurance, Medicaid, Medicare, VA, DoD, TRICARE®, or similar federal or state programs) for reimbursement. All Programs not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Programs at any time without notice. Program details provided upon registration.
Getting started
Once you've enrolled, your Case Manager will call to welcome you to HemAssist within 24 hours. They will conduct an insurance investigation to understand your coverage. Your Clinical Educator will follow up to review everything you need to know about getting started with ELOCTATE, including tips for infusing for the first time. During the first few months on treatment, your Clinical Educator can help you with supplemental infusion training, understanding dosing, and more.
Call 1-833-723-4563 Monday - Friday 8 AM to 7 PM to speak with you Case Manager or Clinical Educator. You can also get started with the resources below.
RESOURCES FOR STARTING ELOCTATE
Support along the way
Starting a new treatment may come with a lot to learn. That’s why, from the moment you enroll, you have a dedicated HemAssist team with support on your side. From digital resources to personalized check-ins, HemAssist is here to help you get started with confidence. Learn more about your team below and enroll to get started with support.
MEET YOUR TEAM
Clinical Educator (CE)
Your Clinical Educator is your point of contact for ELOCTATE education, tips, supplemental infusion training, and ongoing support.
Your Clinical Educator will not provide personal medical advice. For all questions about your individual health needs, consult with your treating physician.
Case Manager
Your Case Manager assists with navigating insurance coverage and identifying the financial support you may be eligible for.
Community Relations and Education Manager (CoRe)
CoRes are dedicated to providing education and empowering those within the hemophilia community through one-to-one communication, as well as through community events and conferences.
REASONS TO REACH OUT
Your Clinical Educator and Case Manager area available to assist you at any point along your ELOCTATE journey.
Your Clinical Educator can provide supplemental infusion training support along with helpful tips about building a treatment routine. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
When you change or start new insurance, you may have questions about affording ELOCTATE. Contact your Case Manager for help navigating the process. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
These are important milestones not only in adulthood, but also in treatment responsibility. Your team can help you navigate life changes such as going to college, starting a new job, or choosing insurance for the first time. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Starting a new treatment takes dedication. Your Clinical Educator can help with tips for building your treatment routine and help maintaining motivation when you need it. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Resources from the community
National Bleeding Disorders Foundation
Hemophilia Federation of America
World Federation of Hemophilia
National Organization for Rare Disorders
This listing is provided as a resource only and does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources on this topic may be available and should be investigated. Sanofi does not review or control the content of non-Sanofi websites.
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
Do not use ELOCTATE if you have had an allergic reaction to it in the past.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.
Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.
If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.
These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.
PLEASE SEE FULL PRESCRIBING INFORMATION
MANUFACTURED BY
Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078
CLICK HERE TO LEARN MORE ABOUT SANOFI'S COMMITMENT TO FIGHTING COUNTERFEIT DRUGS.